Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 178

1.

[Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension].

Blacher J, Halimi JM, Hanon O, Mourad JJ, Pathak A, Schnebert B, Girerd X; Société française d’hypertension artérielle.

Ann Cardiol Angeiol (Paris). 2013 Jun;62(3):132-8. doi: 10.1016/j.ancard.2013.04.009. Epub 2013 May 4. French.

PMID:
23743000
[PubMed - indexed for MEDLINE]
2.

[Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension].

Blacher J, Halimi JM, Hanon O, Mourad JJ, Pathak A, Schnebert B, Girerd X; Société française d’hypertension artérielle.

Presse Med. 2013 May;42(5):819-25. doi: 10.1016/j.lpm.2013.01.022. Epub 2013 Mar 23. French.

PMID:
23528337
[PubMed - indexed for MEDLINE]
3.

Management of hypertension in adults: the 2013 French Society of Hypertension guidelines.

Blacher J, Halimi JM, Hanon O, Mourad JJ, Pathak A, Schnebert B, Girerd X; French Society of Hypertension.

Fundam Clin Pharmacol. 2014 Feb;28(1):1-9. doi: 10.1111/fcp.12044. Epub 2013 Aug 19.

PMID:
23952903
[PubMed - in process]
4.

ESH-ESC guidelines for the management of hypertension.

Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.

Herz. 2006 Jun;31(4):331-8.

PMID:
16810473
[PubMed - indexed for MEDLINE]
5.

Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study.

Bahl VK, Jadhav UM, Thacker HP.

Am J Cardiovasc Drugs. 2009;9(3):135-42. doi: 10.2165/00129784-200909030-00001.

PMID:
19463019
[PubMed - indexed for MEDLINE]
6.

[New treatment strategies for hypertension. Which guidelines and how to apply them].

Blacher J, Baes M, Marchal A, Younes W, Legedz L, Safar M.

Presse Med. 2005 Oct 22;34(18):1279-85. Review. French.

PMID:
16269990
[PubMed - indexed for MEDLINE]
7.

Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study.

Ueng KC, Ningling S, El Maksod A, Hung KY, Yuehui Y.

Clin Drug Investig. 2011;31(9):631-42. doi: 10.2165/11588970-000000000-00000.

PMID:
21591818
[PubMed - indexed for MEDLINE]
8.

Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT study.

de la Sierra A, Roca-Cusachs A, Redón J, Marín R, Luque M, de la Figuera M, Garcia-Garcia M, Falkon L; CENIT Study Working Group.

Clin Drug Investig. 2009;29(7):459-69. doi: 10.2165/00044011-200929070-00004.

PMID:
19499963
[PubMed - indexed for MEDLINE]
9.

2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension.

Chiang CE, Wang TD, Li YH, Lin TH, Chien KL, Yeh HI, Shyu KG, Tsai WC, Chao TH, Hwang JJ, Chiang FT, Chen JH; Hypertension Committee of the Taiwan Society of Cardiology.

J Formos Med Assoc. 2010 Oct;109(10):740-73. doi: 10.1016/S0929-6646(10)60120-9.

PMID:
20970072
[PubMed - indexed for MEDLINE]
10.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

Can J Cardiol. 2009 May;25(5):287-98. Review.

PMID:
19417859
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Ambulatory hypertensive patients treated by cardiologists in France.

Blacher J, Peroz-Froz J, Huberman JP, Ferrini M, Jullien G, Guenoun M, Guedj-Meynier D.

Arch Cardiovasc Dis. 2013 Feb;106(2):86-92. doi: 10.1016/j.acvd.2012.11.002. Epub 2013 Jan 11.

PMID:
23527912
[PubMed - indexed for MEDLINE]
Free Article
12.

[French as 2005-recommendations on the management of arterial hypertension].

Chamontin B, Halimi JM.

Arch Mal Coeur Vaiss. 2007 Jan;100(1):42-6. French.

PMID:
17405553
[PubMed - indexed for MEDLINE]
13.

The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.

Sato A, Watanabe S, Okubo S, Toi T, Doi T, Nakano H, Tada J, Aonuma K; I-HAT investigators.

Hypertens Res. 2010 Dec;33(12):1264-71. doi: 10.1038/hr.2010.175. Epub 2010 Oct 7.

PMID:
20927115
[PubMed - indexed for MEDLINE]
14.

Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.

Mallion JM, Genès N, Vaur L, Clerson P, Vaïsse B, Bobrie G, Chatellier G.

J Hum Hypertens. 2001 Dec;15(12):841-8.

PMID:
11773986
[PubMed - indexed for MEDLINE]
Free Article
15.

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Khan NA, Hemmelgarn B, Padwal R, Larochelle P, Mahon JL, Lewanczuk RZ, McAlister FA, Rabkin SW, Hill MD, Feldman RD, Schiffrin EL, Campbell NR, Logan AG, Arnold M, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Leiter LA, Ogilvie RI, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Burns KD, Ruzicka M, deChamplain J, Pylypchuk G, Gledhill N, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Touyz RM, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2007 May 15;23(7):539-50.

PMID:
17534460
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.

Chrysant SG, Germino FW, Neutel JM.

Am J Cardiovasc Drugs. 2012 Dec 1;12(6):375-89. doi: 10.2165/11636080-000000000-00000. Review.

PMID:
23116225
[PubMed - indexed for MEDLINE]
17.

Using fixed-dose combination therapies to achieve blood pressure goals.

Chrysant SG.

Clin Drug Investig. 2008;28(11):713-34. Review.

PMID:
18840014
[PubMed - indexed for MEDLINE]
18.

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program.

Can J Cardiol. 2004 Jan;20(1):41-54.

PMID:
14968142
[PubMed - indexed for MEDLINE]
19.

The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.

Pool JL, Glazer R, Crikelair N, Levy D.

Clin Drug Investig. 2009;29(12):791-802. doi: 10.2165/11530600-000000000-00000.

PMID:
19888785
[PubMed - indexed for MEDLINE]
20.

Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study.

Obara T, Ohkubo T, Funahashi J, Kikuya M, Asayama K, Metoki H, Oikawa T, Hashimoto J, Totsune K, Imai Y.

J Hypertens. 2005 Sep;23(9):1653-60.

PMID:
16093909
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk